ADPT vs AMGN: Which Stock is Better?
Side-by-side comparison of Adaptive Biotechnologies Corp and Amgen Inc in 2026
ADPT
Adaptive Biotechnologies Corp
$14.86
AMGN
Amgen Inc
$369.53
Key Metrics Comparison
| Metric | ADPT | AMGN | Winner |
|---|---|---|---|
| Market Cap | $2.45B | $199.20B | AMGN |
| P/E Ratio | N/A | 25.84 | AMGN |
| EPS (TTM) | $N/A | $14.30 | AMGN |
| Revenue Growth | 0.5% | 0.1% | ADPT |
| Gross Margin | 74.2% | 70.8% | ADPT |
Analyze ADPT
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ADPT or AMGN a better investment?
Comparing ADPT and AMGN: Adaptive Biotechnologies Corp has a market cap of $2.45B while Amgen Inc has $199.20B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ADPT and AMGN?
ADPT (Adaptive Biotechnologies Corp) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ADPT or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ADPT or AMGN?
ADPT has higher revenue growth at 0.5% vs 0.1% for AMGN.
Which company is more profitable: ADPT or AMGN?
Adaptive Biotechnologies Corp (ADPT) has higher gross margins at 74.2% compared to 70.8% for AMGN.
Which is the larger company: ADPT or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $199.20B compared to $2.45B for ADPT.
Should I buy ADPT or AMGN in 2026?
Both ADPT and AMGN have investment merit. ADPT trades at $14.86 while AMGN trades at $369.53. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ADPT and AMGN stock?
Key differences: Market Cap ($2.45B vs $199.20B), P/E Ratio (N/A vs 25.8x), Revenue Growth (0.5% vs 0.1%), Gross Margin (74.2% vs 70.8%).